BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Guilleman MM, Stevens BAY, Van Lieshout LP, Rghei AD, Pei Y, Santry LA, Thompson B, Wootton SK. AAV-mediated delivery of actoxumab and bezlotoxumab results in serum and mucosal antibody concentrations that provide protection from C. difficile toxin challenge. Gene Ther 2021. [PMID: 33608675 DOI: 10.1038/s41434-021-00236-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Kelly VW, Sirk SJ. Short FcRn-Binding Peptides Enable Salvage and Transcytosis of scFv Antibody Fragments. ACS Chem Biol 2022;17:404-13. [PMID: 35050570 DOI: 10.1021/acschembio.1c00862] [Reference Citation Analysis]
2 Rghei AD, van Lieshout LP, McLeod BM, Pei Y, Lopes JA, Zielinska N, Baracuhy EM, Stevens BAY, Thomas SP, Yates JGE, Warner BM, Kobasa D, Fausther-Bovendo H, Kobinger GP, Karimi K, Thompson B, Bridle BW, Susta L, Wootton SK. Safety and Tolerability of the Adeno-Associated Virus Vector, AAV6.2FF, Expressing a Monoclonal Antibody in Murine and Ovine Animal Models. Biomedicines 2021;9:1186. [PMID: 34572372 DOI: 10.3390/biomedicines9091186] [Reference Citation Analysis]